Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 28Melanoma 25Carcinoma, Renal Cell 22Lung Neoplasms 11Neoplasm Metastasis 10Squamous Cell Carcinoma of Head and Neck 9Neoplasms 9Colorectal Neoplasms 9Prostatic Neoplasms 8Hodgkin Disease 8Carcinoma, Transitional Cell 7Carcinoma, Hepatocellular 7Adenocarcinoma Of Esophagus 7Triple Negative Breast Neoplasms 6Stomach Neoplasms 6Rectal Neoplasms 6Ovarian Neoplasms 6Pancreatic Neoplasms 5Uterine Cervical Neoplasms 4Urinary Bladder Neoplasms 4Nasopharyngeal Carcinoma 4Multiple Myeloma 4Endometrial Neoplasms 4Carcinoma, Merkel Cell 4Carcinoma, Basal Cell 4Brain Neoplasms 4Anus Neoplasms 4Thyroid Neoplasms 3Sarcoma, Kaposi 3Recurrence 3

Interventions

pomalidomide 2plerixafor 1liposomal doxorubicin 1Watchful Waiting 1Transurethral Resection of Prostate 1Nivolumab 1Maraviroc 1Focus Groups 1Benzethonium 1Acetic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acquired Immunodeficiency Syndrome × Nivolumab × 30 days × Clear all
NCT04902443 2026-06-04

Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
58 enrolled
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡